Embed Size (px)
Citation preview
Global Constipation Market Report -----------------------------------------
2016
View Report Details
Executive Summary Constipation is a common medical condition common among elderly and women, and is interpreted differently by patients and physicians.
Constipation can be chronic, sometimes severe, and has a significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three main types of constipation including Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome (IBS-C) and Opioid Induced Constipation (OIC).
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.
The report, “Global Constipation Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S. Japan China and Europe are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.
View Report Details
Growth of the constipation market in the U.S. is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies and increasing patient and physician awareness…
Constipation market of the U.S. reached US$... million in the year 2014, increasing from US$... million in the previous fiscal year recording growth at a CAGR of …% for the period spanning 2011-2014.
The overall prescription volume in the U.S. for constipation reached …. million units in 2014, increasing from …. million prescriptions in the previous year.
Nearly … % of the total constipation market is expected to be captured by generic drugs, followed by …% share from the branded generics. However, the branded drugs (including Amitiza & Linzess) represent merely ….% of the total constipation market in 2015.
The U.S. Constipation Market by Volume (2012-2014)
The U.S. Constipation Market by Value (2011-2014)
The U.S. Constipation Prescription Market by Drug Type (2015E)
2011 2012 2013 2014
US$
Millio
n
2012 2013 2014
Millio
n
Generic Branded Generic Brand Others
China is expected to have a modest market opportunity in future also, resulting from several factors including lower Irritable Bowel Syndrome & Chronic Idiopathic Constipation prevalence rate, low diagnosis rate given lower or little disease awareness and pricing as a limiting factor on the total market opportunity…
The overall constipation prevalence (including IBS-C & CIC) in Japan is estimated to have reached nearly … million of which nearly ..% received medical care or diagnosis for the year 2015.
The market for Amitiza in Japan is expected to reach US$... million by the year 2021, increasing from US$... million in 2015 recording peak penetration of …%.
The overall prevalence of constipation in China is estimated to have reached nearly … million patients for the year 2015. The diagnosis rate however, remained relatively low at … million patients for 2015.
Japan’s Amitiza Drug Market Revenue and Penetration (2015E-2021E)
Japan’s Constipation Market by Volume (2015E- 2025E)
China’s Constipation Market by Volume (2015E-2025E)
2015E 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E 2024E 2025E
Millio
n
Patient Prevalance Patients with Medical Care (%)
2015E 2016E 2017E 2018E 2019E 2020E 2021E
Perc
enta
ge
US$
Millio
n
Sales Penetration Rate (%)
2015E 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E 2024E 2025E
Millio
n
Patient Prevalance Diagnosed Population
In Europe, there exists significant unmet needs including lack of familiarity with IBS-C, difficulty in diagnosis and lack of effective treatments for the multiple symptoms of the disorder...
Nearly … million people in the U.S. are expected to suffer from chronic constipation in the year 2016, increasing from … million patients in the previous fiscal.
There were about … million IBS-C patients in Europe in the year 2014, and about …million of them were under treatment for the same for the given period.
In 2015, nearly … million people had OIC of which … million had undergone treatments for the same. The patient volume under treatment is estimated to reach … million by the end of year 2025.
European IBS-C Market by Volume (2014-2025E)
The U.S. Chronic Constipation Market by Volume (2014-2025E)
European Opioid Induced Constipation Market by Volume (2015-2025E)
2014 2015 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E 2024E 2025E
Millio
n
Patient Prevalance Patients Under-Treatment
2014 2015 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E 2024E 2025E
Millio
n
Patient Prevalence Patients under Treatment2015 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E 2024E 2025E
Millio
n
Patients on Opioid Patients under Treatment
Koncept AnalyticsCS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad, U.P. – 201010
T. +91-120-4130959C: +91-9811715635
Contact Us:
www.konceptanalytics.com
Vikas GuptaBD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Constipation Market ”. To know more about this report or for any customized research requirement, please contact the following:
View Report Details
